Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?
Early glargine administration in pediatric DKA management is safe, decreases the rate of rebound hyperglycemia, and improves the transition to subcutaneous insulin. Hypoglycemia is less frequent following IV insulin discontinuation with early glargine, but the IV insulin rate may need to be reduced to minimize hypoglycemia during IV insulin infusion.
Authors
- Ryan McDonough (ORCID: https://orcid.org/0000-0003-1909-3027)
- G. Todd Alonso (ORCID: https://orcid.org/0000-0002-5676-761X)
- Rebecca A. Ohman-Hanson
- Mark A. Clements (ORCID: https://orcid.org/0000-0002-2368-0331)
- Laura L. Pyle (ORCID: https://orcid.org/0000-0001-5577-8221)
Institutions
- Children's Mercy Hospital (US)
- Colorado School of Public Health (US)
- Children's Hospital Colorado (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Diabetes
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1111/1753-0407.13597
- Citations
- 3
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Dexcom
- Abbott Diabetes Care